How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults

Kamal, Arif H.; Tefferi, Ayalew; Pruthi, Rajiv K.
July 2007
Mayo Clinic Proceedings;Jul2007, Vol. 82 Issue 7, p864
Academic Journal
The prothrombin time (PT) and activated partiai thrombopiastin time (APTT) are among the most commonly ordered coagulation tests. in 2005, more than 140,000 PT and more than 95,000 APTT tests were performed at Mayo Clinic. The most common indications for ordering these tests include anticoagulant monitoring, initial evaluation of hemorrhage, and, although not generally Indicated, routine preoperative screening, in addition, the bleeding time (BT) test, which Is infrequently performed, is still available in certain institutions. Abnormal results from these tests (prolonged PT, APTT, and BT), especially from tests conducted for initial evaluation of hemorrhage or for preoperative screening, may pose, a diagnostic dilemma to the non-hematologist. We review the essential factors affecting test results; provide a practical approach to the evaluation of a prolonged PT, APTT, and BT; and offer suggestions on which reflexive tests are appropriate and when to consider a subspecialty consultation.


Related Articles

  • From Principle to Practice: Bridging the Gap in Patient Profiling. Foley, Jonathan H.; Orfeo, Thomas; Undas, Anetta; McLean, Kelley C.; Bernstein, Ira M.; Rivard, Georges-Etienne; Mann, Kenneth G.; Everse, Stephen J.; Brummel-Ziedins, Kathleen E.; Cate, Hugo ten // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    The standard clinical coagulation assays, activated partial thromboplastin time (aPTT) and prothrombin time (PT) cannot predict thrombotic or bleeding risk. Since thrombin generation is central to haemorrhage control and when unregulated, is the likely cause of thrombosis, thrombin generation...

  • Effect of Tube Filling Order on Specific Coagulation Parameters in Healthy Subjects. Erdinc Serin; Guler Bugdayci // Laboratory Medicine;Sep2007, Vol. 38 Issue 9, p556 

    Background: In this study, the authors attempted to determine if there was any effect of tube filling order on both routine (prothrombin time [PT], activated partial thromboplastin time [APTT], and fibrinogen) and specific coagulation parameters (protein S, protein C, antithrombin III, factor V...

  • The activation of tissue factor by high intensity focused ultrasound--a pathway to acoustic-biochemical hemostasis. Xinmai Yang; Barber, Frank E.; Morrissey, James H.; Church, Charles C. // AIP Conference Proceedings;2006, Vol. 829 Issue 1, p548 

    High intensity focused ultrasound (HIFU) is believed to have great potential for inducing hemostasis in severely bleeding trauma victims. The addition of HIFU-activated biomolecular substances to the blood during treatment could significantly reduce the time required to achieve hemostasis, but...

  • Recombinant Factor VIIA, its Clinical Properties, and the Tissue Factor Pathway of Coagulation. Bosinski, Timothy J.; El Solh, Ali A. // Mini Reviews in Medicinal Chemistry;Oct2006, Vol. 6 Issue 10, p1111 

    Recombinant factor VIIa (rFVIIa) is a synthetic coagulation protease that is structurally similar to humanderived plasma FVIIa. Pharmacologic doses of rFVIIa have been shown to enhance thrombin generation and assist in forming stable fibrin plugs at the site of injury. Recombinant factor VIIa...

  • Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values. Ying Zhao; Jie Zhang; Juanwen Zhang; Jianping Wu // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Objective: This study was designed to examine the relationship between shortened activated partial thromboplastin time (APTT) and increased fibrinogen values with diabetes mellitus. Methods: APTT, prothrombin time (PT), fibrinogen, fasting plasma glucose (FPG) and glycosylated hemoglobin A1c...

  • Change in Blood Coagulation Parameters After Total Body Irradiation. Cengiz, Mustafa; Göker, Hakan; Yazici, Gözde; Zorlu, Faruk; Büyükasik, Yahya; Kirazli, Serafettin; Akman, Ümit; Yildiz, Ferah; Dogan, Ali; Haznedaroglu, Ibrahim C. // International Journal of Hematology & Oncology / UHOD: Uluslarar;Sep2008, Vol. 18 Issue 3, p135 

    We aim to test the changes of coagulation parameters after the TBI by thromboelastography. Eleven patients who underwent TBI between march 2005 and march 2006 in our department were included in this study. Blood samples were taken from all patients immediately before the delivery of TBI and 12...

  • Outpatient Management of Periodontal Patients with Hemophilia. Michaelides, Paul L. // International Journal of Periodontics & Restorative Dentistry;1983, Vol. 3 Issue 5, p64 

    The article focuses on the outpatient management of periodontal patients suffering from hemophilia. An overview of the phenomenon of achieving normal hemostasis, when a blood vessel is severed, is offered. Screening tests for hemostatic function in hemophilia reveal a normal bleeding and...

  • Nonacog-α/prothrombin complex concentrate.  // Reactions Weekly;Sep2015, Vol. 1568 Issue 1, p208 

    The article presents case studies of 11 patents who developed factor IX (FIX) inhibition (FIX) during treatment with prothrombin complex concentrate and nonacog-α.

  • The progress of prothrombin time measurement. Horsti, Juha // Hematology Reviews;2009, Vol. 1 Issue 2, p99 

    Warfarin is the most widely used medicine for oral anticoagulant therapy (OAT). It inhibits the synthesis of coagulation factors II, VII, IX, and X in the liver and results in the production of inactive or partially active versions of these factors. Inactive coagulation factors interfere with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics